The research goal is the improvement of risk prediction in cardiovascular disease. In epidemiological studies, the prognostic value of empirically determined combinations of biomarkers is investigated. A focus is the relationship between parameters of lipoprotein metabolism and biomarkers for inflammation, endothelial dysfunction, renal function, oxidative stress and atherosclerosis.

Funding: ca. 610.000 €, including 205.000 from peer-review projects

 

PI

Assoz.-Prof. Priv.-Doz. Dr.
Hubert Scharnagl 
T: +43 316 385 86030
Oops, an error occurred! Code: 20240502180721739e3e9e